Skip to main content
. 2023 May 10;11:1167104. doi: 10.3389/fpubh.2023.1167104

Table 4c.

Motivation, health-related quality of life, HIV treatment engagement, and HIV viral load over time (Mean [SD] or percent).

Baseline Follow-Up One Follow-Up Two
No MI (n = 40) Yes MI (n = 40) No MI (n = 30) Yes MI (n = 30) No MI (n = 33) Yes MI (n = 25)
Motivation (0–100)
Motivation for HIV Care 95.6 (6.25) 85.4 (21.3) 95.3 (6.69) 95.1 (8.06) 96.0 (6.49) 95.4 (9.53)
Motivation for High HIV Medication Adherence 89.1 (16.5) 76.1 (26.5) 91.8 (9.21) 95.1 (8.82) 95.9 (5.67) 94.5 (11.6)
Motivation for Undetectable Viral Load 93.0 (13.1) 84.9 (22.0) 91.6 (9.45) 91.5 (18.8) 91.5 (14.5) 94.0 (9.63)
SF-12 health-related quality of life
SF-6D Health utility score 0.704 (0.188) 0.685 (0.187) 0.759 (0.183) 0.725 (0.199) 0.761 (0.170) 0.685 (0.212)
SF-12 Physical Health T-score 45.2 (10.6) 42.7 (12.3) 46.7 (11.3) 43.7 (10.6) 48.4 (9.98) 43.4 (12.1)
SF-12 Mental Health T-score 45.3 (11.9) 46.1 (13.1) 48.7 (9.35) 49.1 (11.7) 46.2 (10.2) 45.3 (12.2)
HIV treatment engagement
HIV medication adherence (0–100) 61.4 (41.2) 55.4 (38.6) 70.1 (24.1) 67.7 (30.7) 73.2 (26.3) 75.2 (19.7)
HIV medication taken in past 4 weeks 31 (77.5%) 31 (77.5%) 28 (93.3%) 29 (96.7%) 33 (100%) 25 (100%)
HIV viral load
log10 HIV viral load 3.80 (0.87) 4.04 (0.94) 3.26 (1.38) 3.41 (1.59) 2.96 (1.43) 3.36 (1.71)
Suppressed (viral load < 200) 0 (0%) 0 (0%) 8 (24.2%) 8 (27.6%) 12 (35.3%) 8 (30.8%)

At Follow-Up One, viral load was available for 29 participants assigned to MI sessions and 33 participants not assigned to MI sessions. At Follow-Up Two, viral load was available for 34 participants assigned to MI sessions and 26 participants not assigned to MI sessions.